May 21, 2015
Otsuka Pharmaceutical will roll out on May 25 its schizophrenia treatment Abilify (aripiprazole) extended-release injectable suspension for intramuscular use, it said on May 20. The agent is administered only once monthly at medical institutions, while the oral formulation is administered...read more